Hologic (HOLX) closed at $72.68 in the latest trading session, marking no change from the prior day.
Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Via an agreement with the CDC, Hologic is set to develop ASRs for launching the H5N1 bird flu test.
Hologic (HOLX) closed the most recent trading day at $70.76, moving -0.99% from the previous trading session.
Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Despite the current challenges, HOLX's portfolio strength and international growth prospects make it worth holding on to.
Hologic upholds its focus on equity with new research findings on its Breast Imaging AI solution.
Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
HOLX will unveil breakthrough innovations at this year's RSNA, focusing on imaging solutions and AI.
Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
HOLX's strength in the Molecular Diagnostics wing instills optimism among investors. Yet, macro woes and currency impacts raise concerns.
Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.